Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 14


Genomic alterations in pancreatic cancer and their relevance to therapy.

Takai E, Yachida S.

World J Gastrointest Oncol. 2015 Oct 15;7(10):250-8. doi: 10.4251/wjgo.v7.i10.250. Review.


Assessing the benefit-risk of new treatments using generalised pairwise comparisons: the case of erlotinib in pancreatic cancer.

Péron J, Roy P, Ding K, Parulekar WR, Roche L, Buyse M.

Br J Cancer. 2015 Mar 17;112(6):971-6. doi: 10.1038/bjc.2015.55.


Does ablation technique utilized in the management of unresectable locally advanced pancreatic adenocarcinoma?

Pezzilli R, Fabbri D, Imbrogno A.

Cancers (Basel). 2010 Dec 10;2(4):2098-9. doi: 10.3390/cancers2042098.


Commentary on pancreatic carcinoma: the role of radiofrequency ablation in advanced disease.

Spiliotis J.

Cancers (Basel). 2010 Dec 8;2(4):2055-7. doi: 10.3390/cancers2042055.


The problems of radiofrequency ablation as an approach for advanced unresectable ductal pancreatic carcinoma.

Pezzilli R, Ricci C, Serra C, Casadei R, Monari F, D'Ambra M, Corinaldesi R, Minni F.

Cancers (Basel). 2010 Jul 1;2(3):1419-31. doi: 10.3390/cancers2031419.


Pancreatic cancer genomics: insights and opportunities for clinical translation.

Makohon-Moore A, Brosnan JA, Iacobuzio-Donahue CA.

Genome Med. 2013 Mar 28;5(3):26. doi: 10.1186/gm430. eCollection 2013. Review.


The impact of simultaneous liver resection for occult liver metastases of pancreatic adenocarcinoma.

Klein F, Puhl G, Guckelberger O, Pelzer U, Pullankavumkal JR, Guel S, Neuhaus P, Bahra M.

Gastroenterol Res Pract. 2012;2012:939350. doi: 10.1155/2012/939350. Epub 2012 Nov 8.


Hepaticocholecystoenterostomy as an alternative to hepaticojejunostomy for biliary bypass.

Gani J, Lewis K.

Ann R Coll Surg Engl. 2012 Oct;94(7):472-5. doi: 10.1308/003588412X13171221592294.


Semi mature blood dendritic cells exist in patients with ductal pancreatic adenocarcinoma owing to inflammatory factors released from the tumor.

Tjomsland V, Spångeus A, Sandström P, Borch K, Messmer D, Larsson M.

PLoS One. 2010 Oct 15;5(10):e13441. doi: 10.1371/journal.pone.0013441.


Pancreatic adenocarcinoma exerts systemic effects on the peripheral blood myeloid and plasmacytoid dendritic cells: an indicator of disease severity?

Tjomsland V, Sandström P, Spångeus A, Messmer D, Emilsson J, Falkmer U, Falkmer S, Magnusson KE, Borch K, Larsson M.

BMC Cancer. 2010 Mar 9;10:87. doi: 10.1186/1471-2407-10-87.


Accomplishments in 2008 in the treatment of metastatic pancreatic cancer.

Heinemann V, Philip PA, Pelzer U.

Gastrointest Cancer Res. 2009 Sep;3(5 Supplement 2):S43-7.


DPC4 gene status of the primary carcinoma correlates with patterns of failure in patients with pancreatic cancer.

Iacobuzio-Donahue CA, Fu B, Yachida S, Luo M, Abe H, Henderson CM, Vilardell F, Wang Z, Keller JW, Banerjee P, Herman JM, Cameron JL, Yeo CJ, Halushka MK, Eshleman JR, Raben M, Klein AP, Hruban RH, Hidalgo M, Laheru D.

J Clin Oncol. 2009 Apr 10;27(11):1806-13. doi: 10.1200/JCO.2008.17.7188. Epub 2009 Mar 9.


A phase I trial of Capecitabine+Gemcitabine with radical radiation for locally advanced pancreatic cancer.

Michael M, Price T, Ngan SY, Ganju V, Strickland AH, Muller A, Khamly K, Milner AD, Dilulio J, Matera A, Zalcberg JR, Leong T.

Br J Cancer. 2009 Jan 13;100(1):37-43. doi: 10.1038/sj.bjc.6604827. Epub 2008 Dec 16.


Effects of alpha-adrenoreceptor antagonists on apoptosis and proliferation of pancreatic cancer cells in vitro.

Shen SG, Zhang D, Hu HT, Li JH, Wang Z, Ma QY.

World J Gastroenterol. 2008 Apr 21;14(15):2358-63.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk